These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 12625779)

  • 21. Gene arrays and proteomics. A primer.
    Moulédous L; Gutstein HB
    Methods Mol Med; 2003; 84():141-54. PubMed ID: 12703322
    [No Abstract]   [Full Text] [Related]  

  • 22. From proteins to proteomics.
    Bradshaw RA; Burlingame AL
    IUBMB Life; 2005; 57(4-5):267-72. PubMed ID: 16036609
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Molecular medicine--personalized medicine. Principles and state-of-the-art].
    Blum HE
    Dtsch Med Wochenschr; 2005 Jun; 130(25-26):1568-72. PubMed ID: 15965865
    [No Abstract]   [Full Text] [Related]  

  • 24. Comparative analysis of the membrane proteome of closely related metastatic and nonmetastatic tumor cells.
    Roesli C; Borgia B; Schliemann C; Gunthert M; Wunderli-Allenspach H; Giavazzi R; Neri D
    Cancer Res; 2009 Jul; 69(13):5406-14. PubMed ID: 19491280
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Proteomic approaches to the discovery of cancer biomarkers for early detection and personalized medicine.
    Honda K; Ono M; Shitashige M; Masuda M; Kamita M; Miura N; Yamada T
    Jpn J Clin Oncol; 2013 Feb; 43(2):103-9. PubMed ID: 23248327
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Protein- versus peptide fractionation in the first dimension of two-dimensional high-performance liquid chromatography-matrix-assisted laser desorption/ionization tandem mass spectrometry for qualitative proteome analysis of tissue samples.
    Melchior K; Tholey A; Heisel S; Keller A; Lenhof HP; Meese E; Huber CG
    J Chromatogr A; 2010 Oct; 1217(40):6159-68. PubMed ID: 20810122
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Protein profiling for cancer biomarker discovery using matrix-assisted laser desorption/ionization time-of-flight mass spectrometry and infrared imaging: a review.
    Bakry R; Rainer M; Huck CW; Bonn GK
    Anal Chim Acta; 2011 Mar; 690(1):26-34. PubMed ID: 21414433
    [TBL] [Abstract][Full Text] [Related]  

  • 28. MALDI mass spectrometry imaging in oncology (Review).
    Gemoll T; Roblick UJ; Habermann JK
    Mol Med Rep; 2011; 4(6):1045-51. PubMed ID: 21874241
    [TBL] [Abstract][Full Text] [Related]  

  • 29. State-of-the-art nanoplatform-integrated MALDI-MS impacting resolutions in urinary proteomics.
    Gopal J; Muthu M; Chun SC; Wu HF
    Proteomics Clin Appl; 2015 Jun; 9(5-6):469-81. PubMed ID: 25736343
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Molecular oncology in the post-genomic era: the challenge of proteomics.
    Mocellin S; Rossi CR; Traldi P; Nitti D; Lise M
    Trends Mol Med; 2004 Jan; 10(1):24-32. PubMed ID: 14720583
    [No Abstract]   [Full Text] [Related]  

  • 31. [Molecular diagnostics of ovarian cancer using proteome techniques].
    Vlasova MA; Moshkovskiĭ SA; Safarova MP; Makarov OV; Archakov AI
    Biomed Khim; 2005; 51(4):367-83. PubMed ID: 16223028
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Serum, salivary and tissue proteomics for discovery of biomarkers for head and neck cancers.
    Drake RR; Cazare LH; Semmes OJ; Wadsworth JT
    Expert Rev Mol Diagn; 2005 Jan; 5(1):93-100. PubMed ID: 15723595
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Integrative oncoproteomics strategies for anticancer drug discovery.
    Liu R; Wang K; Yuan K; Wei Y; Huang C
    Expert Rev Proteomics; 2010 Jun; 7(3):411-29. PubMed ID: 20536311
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Matrix-assisted laser desorption/ionization time-of-flight mass spectrometry and proteomics: a new era in anaerobic microbiology.
    Shah HN; Keys CJ; Schmid O; Gharbia SE
    Clin Infect Dis; 2002 Sep; 35(Suppl 1):S58-64. PubMed ID: 12173110
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Personalized medicine in oncology: tailoring the right drug to the right patient.
    Jiang Y; Wang M
    Biomark Med; 2010 Aug; 4(4):523-33. PubMed ID: 20701441
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Genomic and proteomic analysis of mammary tumors arising in transgenic mice.
    Xie L; Xu BJ; Gorska AE; Shyr Y; Schwartz SA; Cheng N; Levy S; Bierie B; Caprioli RM; Moses HL
    J Proteome Res; 2005; 4(6):2088-98. PubMed ID: 16335954
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Practical cancer genetics, genomics and proteomics.
    Gruber MP; Geraci MW
    J Insur Med; 2005; 37(3):190-200. PubMed ID: 16259209
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Pharmacogenomics in neuro-oncology].
    Riese-Jorda HH; Baez JM
    Rev Neurol; 2006 Sep 16-30; 43(6):353-6. PubMed ID: 16981166
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Proteomic profiling by nanomaterials-based matrix-assisted laser desorption/ionization mass spectrometry for high-resolution data and novel protein information directly from biological samples.
    Kailasa SK; Wu HF
    Methods Mol Biol; 2015; 1295():479-96. PubMed ID: 25820742
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Integrated proteo-genomic approach for early diagnosis and prognosis of cancer.
    Shukla HD; Mahmood J; Vujaskovic Z
    Cancer Lett; 2015 Dec; 369(1):28-36. PubMed ID: 26276717
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.